These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27284967)

  • 1. Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity.
    Kashima H; Momose F; Umehara H; Miyoshi N; Ogo N; Muraoka D; Shiku H; Harada N; Asai A
    PLoS One; 2016; 11(6):e0156643. PubMed ID: 27284967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.
    Casares N; Rudilla F; Arribillaga L; Llopiz D; Riezu-Boj JI; Lozano T; López-Sagaseta J; Guembe L; Sarobe P; Prieto J; Borrás-Cuesta F; Lasarte JJ
    J Immunol; 2010 Nov; 185(9):5150-9. PubMed ID: 20870946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoteichoic acid of Bifidobacterium in combination with 5-fluorouracil inhibit tumor growth and relieve the immunosuppression.
    Xie N; Wang Y; Wang Q; Li FR; Guo B
    Bull Cancer; 2012 May; 99(5):E55-63. PubMed ID: 22522606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.
    Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W
    J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
    Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
    J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration with diosgenin enhances the induction of intestinal T helper 1-like regulatory T cells in a murine model of food allergy.
    Huang CH; Wang CC; Lin YC; Hori M; Jan TR
    Int Immunopharmacol; 2017 Jan; 42():59-66. PubMed ID: 27886644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic blockade of Foxp3 in experimental breast cancer models.
    Moreno Ayala MA; Gottardo MF; Imsen M; Asad AS; Bal de Kier Joffé E; Casares N; Lasarte JJ; Seilicovich A; Candolfi M
    Breast Cancer Res Treat; 2017 Nov; 166(2):393-405. PubMed ID: 28756536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
    Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
    Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.
    Wang L; Hu X; Xu Y; Liu Z
    Tumour Biol; 2016 Nov; 37(11):15165-15173. PubMed ID: 27677289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Inhibition of Foxp3 by MMP2/9 Sensitive Short Peptide Linked P60 Fusion Protein 6(P60-MMPs) to Enhance Antitumor Immunity.
    Ding X; Peng C; Li Y; Liu J; Song Y; Cai B; Xiang M; Zhang J; Wang Z; Wang L
    Macromol Biosci; 2020 Jul; 20(7):e2000098. PubMed ID: 32449306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranuclear interactomic inhibition of FoxP3 suppresses functions of Treg cells.
    Park JH; Ko JS; Shin Y; Cho JY; Oh HA; Bothwell AL; Lee SK
    Biochem Biophys Res Commun; 2014 Aug; 451(1):1-7. PubMed ID: 25044110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.
    Wan YY; Flavell RA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5126-31. PubMed ID: 15795373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
    Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
    Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.